A biological starting system is not a freezer item. Its identity is the lineage connecting source, construct or strain, derivation, passages, characterization, bank manufacture, storage, vial history, authorized use, and every production culture that follows.
When those facts are divided between inventory, laboratory notebooks, freezer maps, certificates, batch records, and individual recollection, the organization can know how many vials remain without knowing which ones may be used—or which released products are affected by a newly discovered concern.
The biological source retains its provenance
Species, tissue or isolate, donor or host where applicable, collection, depositor, source organization, geographic and temporal origin, clinical or research history, biosafety, genetic background, and restrictions remain attached to the source.
For recombinant systems, construct identity, sequence version, vector, clone selection, integration or editing history, and expression phenotype join the lineage without reducing the bank to a material code.
Master and working cell banks, master and working virus seeds, bacterial or fungal seed lots, production strains, challenge organisms, and reference cultures share parentage, generation, characterization, storage, container, withdrawal, and use concepts.
Their specific controls remain explicit: passage terminology, multiplicity, host system, attenuation, adventitious-agent expectations, phenotypic stability, viability, potency, purity, or strain authentication can vary by organism and purpose.
Derivation is an executable lineage
The approved derivation defines source material, culture conditions, media and critical raw materials, vessels, single-use components, manipulations, clone or plaque selection, passages, pool and split events, harvest, formulation, fill, freeze, sampling, and reconciliation.
Actual execution records every transformation. A bank lot is connected to the precise parent container and culture history—not merely to a protocol title.
Passage and generation are calculated, not transcribed
The model preserves the organization's approved convention and computes passage or generation from recorded events. Population doublings, culture duration, split ratio, inoculation, harvest, and any exceptional manipulation remain available where relevant.
Maximum passage, generation, or population-doubling limits gate both bank creation and production use. Manual overrides require a visible rationale and authorization.
Characterization is a planned body of evidence
Identity, purity, sterility, mycoplasma, adventitious agents, viral testing, genetic stability, phenotype, expression, viability, potency, bacteriophage, antibiotic resistance, tumorigenicity, or other studies resolve by bank type, organism, product, stage, and market.
The FDA Biotechnology Inspection Guide describes attention to cell-bank origin, history, characterization, and controls. Seal makes those dependencies queryable rather than assembling them only for an inspection.
Bank release can carry conditions
Release requirements can include completed results, acceptable interim evidence, future commitments, restricted uses, maximum passages, named products or facilities, geographic limits, and requalification dates.
Quarantine, conditionally authorized, released, restricted, exhausted, superseded, under investigation, and retired states are distinct. Availability derives from quality state as well as vial count.
Every vial has identity and physical position
Bank lot, fill event, container type, vial number or range, aliquot, box, rack, freezer, tank, cane, cassette, site, and storage phase form the physical hierarchy. Moves use scan-confirmed source and destination.
Bulk moves, emergency relocations, split storage, and disaster-recovery holdings preserve individual position history and outstanding confirmation rather than replacing the previous map.
Storage state is part of suitability
Freezer or cryogenic-vessel state, temperature, liquid-nitrogen level, alarm, calibration, maintenance, access, backup, room condition, and excursion evidence connect to the vial population present during the interval.
An excursion impact therefore resolves to exact bank lots and vials, including those moved during the event.
Withdrawal is a chain-of-custody event
Reservation, authorization, pick, identity verification, location confirmation, removal time, transport condition, receipt, thaw start, remaining position, and intended use remain one transaction.
Unused vials cannot casually return to stock. The approved policy evaluates temperature, time, seal, custody, and intended-use history before any return or alternative disposition.
A thaw begins a downstream lineage
The vial connects to thaw conditions, recovery, culture vessel, medium and supplement lots, operator, equipment, viability, contamination checks, passage events, seed train, and production batch.
That connection supports both forward trace from a bank concern to product and backward trace from a process signal to the exact source vial.
Contamination and identity events expand through genealogy
A failed sterility, mycoplasma, identity, adventitious-agent, strain-
Scope is versioned as evidence changes. Investigators can see why a lineage was included or excluded at each decision.
Vial counts reconcile with the fill event
Filled, sampled, retained, shipped, stored, broken, warmed, withdrawn, returned where allowed, destroyed, and remaining vial populations must reconcile.
The system distinguishes physical count uncertainty from quality-status uncertainty. Neither can be hidden behind a single available quantity.
Reserve strategy is visible before scarcity
Minimum reserve, working-life forecast, program demand, manufacturing schedule, testing consumption, stability pulls, disaster-recovery allocation, fill yield, and lead time indicate when a new bank is required.
The planner sees not just exhaustion date but the characterization and comparability path needed before the replacement may support production.
Requalification and stability follow the bank lifecycle
Periodic or event-driven monitoring can assess viability, identity, genetic or phenotypic stability, potency, container integrity, and storage history. Pulls are selected from governed positions and remain linked to their analytical methods and results.
A new signal can alter bank authorization and initiate product-impact review without rewriting historical dispositions.
Transfers preserve scientific and legal constraints
Intercompany, intersite, contract manufacturer, testing laboratory, or repository transfer carries chain of custody, shipping configuration, permit or agreement, biosafety, source restrictions, receipt verification, and location integration.
Recipient identifiers can map to the source identity without creating an untraceable parallel lineage.
Changes begin at the affected generation
New working bank, changed medium, raw-material source, vessel, process, passage limit, storage system, characterization method, site, or container identifies its first affected bank and all intended descendants.
Comparability and regulatory commitments attach to that branch. Pre-change and post-change production are related, but never treated as the same evidence population by default.
Where Seal is strongest
Seal is strongest at the boundary between cryogenic inventory and biological genealogy. A repository system can manage boxes; a LIMS can manage tests; an MES can manage culture execution. Seal connects them to the authorization question: can this vial initiate this use now, and what would be affected if its lineage changes?
The model supports biologics, vaccines, viral vectors, cell therapies, microbial fermentation, challenge organisms, and reference strains without flattening their scientific differences.
Prove one difficult lineage end to end
The first implementation should follow one source through construct or strain identity, clone selection, master bank manufacture, characterization, conditional release, working bank derivation, cryogenic positions, excursion, vial reservation and withdrawal, thaw, seed train, production batch, testing, product release, later identity concern, and impact assessment.
Include a mis-scanned location, broken vial, partial characterization result, passage-limit edge, emergency freezer move, unsuccessful thaw, returned shipment, new working bank, and a result that expands scope to sibling vials but excludes an unrelated branch. The first usable release must answer both which vial can be used and every product descended from it.
